TSX-V:PCRX - TSX Venture Exchange - CA71714X1050 - Common Stock - Currency: CAD
SASKATOON, Saskatchewan, Nov. 26, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce the...
PharmaCorp completes acquisition of pharmacy in Atlantic Canada...
SASKATOON, Saskatchewan, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce...
SASKATOON, Saskatchewan, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce...
REGINA, Saskatchewan, Aug. 22, 2024 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that...